Advanced Cancer
Therapeutics Awarded Phase I SBIR Grant to Develop Anti-Cancer Drug
for Novel Cancer Metabolism Target October
11, 2012 click
here
U.S. Granted Patent
8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer
Product Portfolio April
3,
2012 click
here
Dr. Gilles Tapolsky,
Chief Scientific Officer, will present at the annual World
Cancer Metabolism Summit February 1 - 2, 2012 in Washington,
D.C. Presentation will be
on ACT’s novel cancer metabolism programs. January
30,
2012 click
here
Randall Riggs,
President & CEO, has been selected to present at the MidAmerican Healthcare
Venture Form, November 8-9, 2011 in Louisville, KY. October
19,
2011 click
here
|